Silexion Therapeutics Corp.
05/01/2025 | Press release | Distributed by Public on 05/02/2025 04:04
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 1, 2025 |
| Accession Number: | 0001178913-25-001521 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Silexion Therapeutics Corp. published this content on May 01, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on May 02, 2025 at 10:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io